ATTITUDE OF PATIENTS TO RISK OF LUNG CANCER

Tanyo Stefanov

Abstract


The article presents a study of patients' attitudes toward lung cancer risk. Most or almost half of the respondents believe that only some of them are aware of the risk factors in question. About one-third of the participants in our study stated that they were completely unfamiliar, and only 20.24 ± 0.18% of all respondents were confident in their knowledge of the risk factors we examined.

Keywords


attitude, risk, patients

Full Text:

PDF

References


Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N (January 2002). Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax. BMJ Publishing Group. 57 (1): 20–8. doi:10.1136/thorax.57.1.20. PMC 1746188. PMID 11809985.

Fuld AD, Dragnev KH, Rigas JR (June 2010). Pemetrexed in advanced non-small-cell lung cancer. Expert Opin Pharmacother. 11 (8): 1387–402. doi:10.1517/14656566.2010.482560. PMID 20446853.

Santos FN, de Castria TB, Cruz MR, Riera R (October 2015). Chemotherapy for advanced non-small cell lung cancer in the elderly population. The Cochrane Database of Systematic Reviews (10): CD010463. doi:10.1002/14651858.CD010463.pub2. PMID 26482542.

Carbone DP, Felip E (September 2011). Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms. Clinical Lung Cancer. 12 (5): 261–71. doi:10.1016/j.cllc.2011.06.002. PMID 21831720.

Le Chevalier T (October 2010). Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?. Annals of Oncology. 21 Suppl 7 (Suppl. 7): vii196–8. doi:10.1093/annonc/mdq376. PMID 20943614.

Burdett S, Pignon JP, Tierney J, Tribodet H, Stewart L, Le Pechoux C, et al. (March 2015). Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. The Cochrane Database of Systematic Reviews (3): CD011430. doi:10.1002/14651858.CD011430. PMID 25730344.

He J, Shen J, Yang C, Jiang L, Liang W, Shi X, Xu X, He J (June 2015). "Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis. Medicine. 94 (22): e903. doi:10.1097/MD.0000000000000903. PMC 4616365. PMID 26039122.

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 383 (9928): 1561–71. May 2014. doi:10.1016/S0140-6736 (13)62159-5. PMC 4022989. PMID 24576776.

Burdett SS, Stewart LA, Rydzewska L (July 2007). Chemotherapy and surgery versus surgery alone in non-small cell lung cancer. The Cochrane Database of Systematic Reviews (3): CD006157. doi:10.1002/14651858.CD006157.pub2. PMID 17636828.

Noonan, KL; Ho, C; Laskin, J (November 2015). The influence of the evolution of first-line chemotherapy on steadily improving survival in advanced non-small-cell lung cancer clinical trials. Journal of Thoracic Oncology. 10 (11): 1523–, 1531. doi:10.1097/JTO.0000000000000667. PMID 26536194.

Sörenson S, Glimelius B, Nygren P (2001). A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncologica. 40 (2–3): 327–39. doi:10.1080/02841860151116402. PMID 11441939.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N (2001). A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Health Technology Assessment. 5 (32): 1–195. PMID 12065068. Archived from the original on 30 August 2017.

Non-Small Cell Lung Cancer Collaborative, Group (12 May 2010). Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. The Cochrane Database of Systematic Reviews (5): CD007309. doi:10.1002/14651858.CD007309.pub2. PMID 20464750.

D'Antonio C, Passaro A, Gori B, Del Signore E, Migliorino MR, Ricciardi S, Fulvi A, de Marinis F (May 2014). Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Therapeutic Advances in Medical Oncology. 6 (3): 101–14. doi:10.1177/1758834014521110. PMC 3987652. PMID 24790650.

Lazarus DR, Eapen GA (2014). Chapter 16: Bronchoscopic interventions for lung cancer. In Roth JA, Hong WK, Komaki RU. Lung Cancer (4th ed.). Wiley-Blackwell. ISBN 978-1-118-46874-6.


Refbacks

  • There are currently no refbacks.


New knowledge Journal of science Jubilee edition is financed by the National Science Fund of the Republic of Bulgaria – contract № ДНП 05/52 от 22.12.2016 in the competition of Bulgarian scientific periodicals – 2016

The contents of this publication do not necessarily reflect the position or opinion of the National Science Fund of the Republic of Bulgaria. The opinions expressed are those of the author(s) only and should not be considered as representative of the National Science Fund’s official position.

https://www.fni.bg/

National Science Fund of Bulgaria